| Document Date: 2013-09-27 15:15:31
Open Document File Size: 372,64 KBShare Result on Facebook
City Reference / / Company IgG / / IndustryTerm hybridoma technology / purification technologies / treatment of patients with chronic lymphocytic leukemia / medicinal products / colorless solution / parenteral drug products / / MedicalCondition Virus Reactivation Hepatitis B / dyspnea / laryngeal edema / Tumor Lysis Syndrome Tumor lysis syndrome / Headache / HBV / Herpes zoster / chronic lymphocytic leukemia / liver failure / bronchitis / bronchopneumonia / nausea / Muscle spasms / thrombocytopenia / hepatitis B / Hyperhidrosis / syncope / fulminant hepatitis / fatigue / septic shock / Progressive Multifocal Leukoencephalopathy / pulmonary edema / Tachycardia / angina / diarrhea / hepatitis / Sinusitis / prior HBV infection / infections / back pain / respiratory tract infection / sepsis / hypotension / Intestinal Obstruction / abdominal pain / Insomnia / pneumonia / hypertension / bacteremia / bronchospasm / HBV infection / flushing / disease / Nasopharyngitis / dyspnea / Chills / Carcinogenesis / VIRUS REACTIVATION AND PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY / neutropenia / Tumor Lysis Syndrome / Virus Infection Fatal infection / Virus Infection / urticaria / hepatic failure / angioedema / infection / cough / rash / repeated vomiting / lobar pneumonia / hepatitis B. Insufficient / anemia / myocardial ischemia / Syndrome / severe neutropenia / severe chronic obstructive pulmonary disease / upper respiratory tract infections / / MedicalTreatment immunization / Premedication / Immunizations / chemotherapy / intravenous infusion / antiviral therapy / / MusicGroup Nausea / / OperatingSystem Dos / / Organization DOSAGE AND ADMINISTRATION / FDA / ded / / / Position General / / Product acetaminophen / Sodium Chloride / prednisolone / / Technology antibodies / purification technologies / chemotherapy / Pharmacodynamics / / URL www.fda.gov/me / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION These hig hlights do not include all the informatio n nee ded to use ARZERRA safely and effectively. See full prescribing information for ARZERRA. •